Pre-chemotherapy exercise shows promise in reducing cancer-related fatigue
Peer-Reviewed Publication
Updates every hour. Last Updated: 24-Jun-2026 03:16 ET (24-Jun-2026 07:16 GMT/UTC)
A randomized crossover pilot study conducted by researchers at the University of Sherbrooke and the Research Centre on Aging in Quebec, Canada, investigated whether moderate-to-high-intensity aerobic exercise performed the day before chemotherapy could influence cancer-related fatigue and active versus sedentary behaviors in the days following treatment. The study, published in Translational Exercise Biomedicine (ISSN: 2942-6812), an official partner journal of International Federation of Sports Medicine (FIMS), provides preliminary evidence that pre-chemotherapy exercise is safe and may offer modest benefits for fatigue management.
In a study published today in Clinical Cancer Research, scientists at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine found that a blood-based test may help guide treatment decisions for a carefully selected group of women age 70 and over who have estrogen receptor–positive breast cancer, who were considering endocrine (or hormone-blocking) therapy as the primary treatment and forgoing surgery and radiation.